To access the full text documents, please follow this link: http://hdl.handle.net/2445/126334
dc.contributor.author | Llobet, Lara I. de |
---|---|
dc.contributor.author | Baro Serrano, Marta |
dc.contributor.author | Mesía, Ricard |
dc.contributor.author | Balart Serra, Josep |
dc.date | 2018-11-22T11:44:00Z |
dc.date | 2018-11-22T11:44:00Z |
dc.date | 2014-08 |
dc.date | 2018-07-24T12:38:36Z |
dc.identifier.uri | http://hdl.handle.net/2445/126334 |
dc.format | 10 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Elsevier Science Inc |
dc.relation | Reproducció del document publicat a: https://doi.org/10.1016/j.tranon.2014.02.008 |
dc.relation | Translational Oncology, 2014, vol. 7, num. 4, p. 513-522 |
dc.relation | https://doi.org/10.1016/j.tranon.2014.02.008 |
dc.rights | cc by-nc-nd (c) Llobet et al., 2014 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by-nd/3.0/es/ |
dc.subject | Càncer |
dc.subject | Medicaments antineoplàstics |
dc.subject | Cancer |
dc.subject | Antineoplastic agents |
dc.title | Simvastatin Enhances the Effects of Radiotherapy and Cetuximab on a Cell Line (FaDu) Derived from a Squamous Cell Carcinoma of Head and Neck |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |